The low expression of circMTO1 may predict big tumor size, poor differentiation and worse outcome of cancer, presenting that circMTO1 may be a useful biomarker for prognosis of tumors.
Investigation of the clinicopathological and prognostic role of circMTO1 in multiple cancers.